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Abstract
Blood pressure (BP) assessment and management are important aspects of care for
youth with obesity. This study evaluates data of youth with obesity seeking care at
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35 pediatric weight management (PWM) programs enrolled in the Pediatric Obesity
Weight Evaluation Registry (POWER). Data obtained at a first clinical visit for youth
aged 3–17 years were evaluated to: (1) assess prevalence of BP above the normal
range (high BP); and (2) identify characteristics associated with having high BP status.
Weight status was evaluated using percentage of the 95th percentile for body mass
index (%BMIp95); %BMIp95 was used to group youth by obesity class (class 1, 100%
to < 120% %BMIp95; class 2, 120% to < 140% %BMIp95; class 3, ≥140% %BMIp95;
class 2 and class 3 are considered severe obesity). Logistic regression evaluated associations with high BP. Data of 7943 patients were analyzed. Patients were: mean
11.7 (SD 3.3) years; 54% female; 19% Black non-Hispanic, 32% Hispanic, 39% White
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non-Hispanic; mean %BMIp95 137% (SD 25). Overall, 48.9% had high BP at the baseline visit, including 60.0% of youth with class 3 obesity, 45.9% with class 2 obesity, and
37.7% with class 1 obesity. Having high BP was positively associated with severe obesity, older age (15–17 years), and being male. Nearly half of treatment-seeking youth
with obesity presented for PWM care with high BP making assessment and management of BP a key area of focus for PWM programs.
KEYWORDS

blood pressure, hypertension, obesity, pediatric weight management, pediatrics

INTRODUCTION

Using current guideline interpretations for BP,7 national samples
report 27.5% of youth ages 12–19 years with obesity had BP above

Child/adolescent obesity strongly tracks into adulthood1,2 and con-

a normal range (ie, elevated, stage 1, or stage 2 classification; hence-

veys an increased risk for morbidity and mortality of cardiovascular

forth, high BP); and 30.6% of youth with severe obesity (defined as body

disease in adulthood, with the strength of the relationship to risk for

mass index [BMI]-for-age ≥120% of the 95th percentile) had high BP.8

cardiovascular disease increasing as the child

ages.3,4

Obesity is an

A recent report evaluated BP among national samples of youth ages 8–

established risk factor for hypertension in youth and risk increases

12 years and 13–17 years, reporting 2–3 times higher risk for high BP

with severity of obesity.5 A systematic review of 19 studies reported

among youth with obesity as compared to youth of normal weight, but

that youth with elevated blood pressure (BP) were more likely to have

youth with severe obesity were not separately evaluated.9

increased risk for markers of cardiovascular disease (such as high pulse

Because treatment of high BP in childhood could potentially reduce

wave velocity, high carotid intima-media thickness, left ventricular

long-term cardiovascular risks, it is of particular importance to under-

hypertrophy) in adulthood.6 Thus, recognition of elevated BP by

stand prevalence and risks for high BP among youth with obesity

standardized BP measurement, and interpretation and early man-

in the clinical setting to plan for their evaluation and management

agement are important aspects of optimal clinical care for youth with

needs. This study evaluates data obtained in the Pediatric Obesity

obesity.

Weight Evaluation Registry (POWER). POWER is a consortium of
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multicomponent pediatric weight management (PWM) programs

or < - 3.9), patients with height-for-age extreme values at their initial

across the United States which prospectively enrolls patients seeking

visit were excluded from these analyses.

obesity management care and tracks parameters of care in an aggre-

Among 8933 active POWER participants, 990 (11.1%) were

gate database.10 Three-quarters of youth in POWER present with

excluded from analyses; initial visit data of 7943 patients (88.9%) were

severe obesity.11 This study aims to evaluate data from youth enrolled

analyzed. There were 107 (1.2%) excluded due to age missing, age < 3

in POWER to: (1) assess prevalence of high BP in the clinical setting

years, or age ≥18 years, 509 (5.7%) excluded due to missing height or

among care-seeking youth with obesity; and (2) identify characteristics

weight or BP, 299 (3.3%) had BMI < 95th BMI percentile, and 75 (0.8%)

associated with high BP status at a baseline visit.

had extreme height-for-age values.
Data were used to compute percentage of the 95th percentile
for BMI (%BMIp95) and height z-score (HtZ) based on CDC 2000

2

METHODS

references.13 BP interpretations were done using references in the
2017 guideline (SAS macro).7 Obesity class groups were defined as fol-

POWER was established in 2014 with the aim to better understand

lows: class 1, 100% to < 120% %BMIp95; class 2, 120% to < 140%

the complex nature of PWM and to collectively evaluate and improve

%BMIp95; class 3, ≥140% %BMIp95; classes 2 and 3 were considered

medical care strategies for children and adolescents with obesity

severe obesity.14

and improve health

outcomes.10

The Data Coordinating Center for

POWER is located at Cincinnati Children’s Hospital Medical Center.
POWER leadership supports POWER’s infrastructure, which include

2.1

Analyses

an aggregate database and collaborative work, such as research and
educational webinars. Financial support for POWER is provided via

The frequency and percentage of patients overall, and for normal BP

enrollment fees paid biannually by individual sites, with oversight pro-

and high BP groups are presented. To evaluate associations with sex,

vided by POWER’s administrative staff at Cincinnati Children’s Hospi-

age group, race/ethnicity, insurance group, age, %BMIp95, and HtZ, as

tal Medical Center.

appropriate, Pearson’s chi-square test was used to compare binary or

The Cincinnati Children’s Hospital Institutional Review Board

nominal categorical variables, and the Kruskal-Wallis test was used to

approved this study. Additionally, Institutional Review Boards at

compare continuous variables or ordinal categorical variables across

each site approved the study and monitored the site-specific con-

BP group status. Additionally, for each BP interpretation category (nor-

sent/assent process. The POWER study is registered with Clini-

mal, elevated, stage 1, stage 2) descriptive data for these same categor-

cal.Trials.gov (NCT02121132).

ical and continuous variables are presented.

Patients evaluated were prospectively recruited from 35 participat-

A mixed-effects logistic regression model, with site as a random

ing sites in May 2014 through December 2017. Not all sites partici-

effect to account for multi-site sampling, was used to evaluate the

pated for the entire data period, as some joined POWER later during

associations of factors with BP group status (normal BP vs. high BP

the study period.

group). Factors in the model included categorical variables of sex, age

Each site contributed data to a central database. Database elements

group, race/ethnicity, insurance group, and obesity class group. To fur-

included patient demographics (race, ethnicity, insurance type) and

ther focus on youth with BP interpreted as stage 1 or stage 2 hyper-

characteristics (sex, age, weight, height, BP). One BP measurement was

tension, a second mixed-effects logistic regression model applied the

entered for each patient visit; documentation of the BP measurement

same methods to examine associations of factors with BP interpreta-

procedure (eg, electronic or manual measure, or if it was a report of an

tion group status between the combined normal BP and elevated BP

average of repeated BP measurements) was not obtained. Additionally,

groups (normal/elevated group) versus the group of youth with stage 1

there was no information on BP measurement practices as protocols

or stage 2 hypertension (stage 1/stage 2 group). Patients with missing

by site were not available; however, POWER did provide written BP

race/ethnicity or insurance group were excluded from logistic regres-

assessment recommendations to sites based on Centers for Disease

sion analyses.

Control and Prevention (CDC) guidelines12 within a Data Definitions

Frequency of BP interpretation groups by site are reported. All anal-

Document. The registry included optional data entry for patient diag-

yses were performed using SAS software version 9.4 (SAS Institute Inc.,

noses/conditions (eg, hypertension) existing at the time of the initial

Cary, NC, USA).

PWM visit and for medications/treatments (eg, antihypertensive medications) at the time of the initial PWM visit. However, these fields were
not uniformly completed so were not considered in analyses. Thus,

3

RESULTS

some youth included in these analyses had hypertension and may been
taking antihypertensive medication before their initial PWM visit.
Data of patients aged 3–17 years with valid BP, height and weight

Data on 7943 patients were analyzed; 54% were females. Patients
were most often either Hispanic (32%) or White non-Hispanic (NH)

measures, and body mass index (BMI) for age ≥95th percentile at an

(39%) and 59% had public health insurance (Table 1). Mean age was

initial visit were evaluated. Because BP guidelines lack interpretations

11.7 years (SD 3.3); about half (47%) of patients were aged 12–

for patients at extreme height-for-age (height z-score [HtZ] > 3.9

18 years; a majority (73%) had severe obesity. There were 35 sites
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TA B L E 1

Patient characteristics by blood pressure status group

Variable

Level

Overall (N = 7943)
n
%

Grouped by BP Status
Normal BP
(N = 4061, 51.1%)
n
%

High BPa
(N = 3882, 48.9%)
n
%

p-valuec

<.0001

Categorical variables
Age group, yearsd

Sex
Race/ethnicity

Primary health
insurance

Obesity Classb

3–5

367

4.6

192

52.3

175

47.7

6–10

1296

16.3

711

54.9

585

45.1

9–11

2547

32.1

1380

54.2

1167

45.8

12–14

2197

27.7

1153

52.5

1044

47.5

15–17

1536

19.3

625

40.7

911

59.3

Male

3668

46.2

1704

46.5

1964

53.5

Female

4275

53.8

2357

55.1

1918

44.9

Black NH

1495

18.8

810

54.2

685

45.8

Hispanic

2503

31.5

1304

52.1

1199

47.9

White NH

3129

39.4

1557

49.8

1572

50.2

Other and multiracial NH

429

5.40

228

53.1

201

46.9

Unknown

387

4.9

162

41.9

225

58.1

Private

2331

29.3

1155

49.6

1176

50.4

Public

4669

58.8

2381

51.0

2288

49.0

Self-pay/none

65

0.8

33

50.8

32

49.2

Unknown

878

11.1

492

56.0

386

44.0

Class 1

2166

27.3

1350

62.3

816

37.7

Class 2

2854

35.9

1543

54.1

1311

45.9

Class 3

2923

36.8

1168

40.0

1755

60.0

Median

7943

11.7

4061

11.5

3882

12.0

<.0001
.0001

.0127

<.0001

Continuous variablesd
Age, years

25th

%BMIp95

9.5

75th

14.3

13.8

14.8

11.7

11.5

12.0
3.4

STD

3.3

3.2

Min

3.0

3.0

3.0

Max

18.0

18.0

18.0

Median

7943

132.1

4061

118.8

128.3

3882

115.9

136.9

148.5

143.0

154.8

Mean

136.6

131.8

141.6

STD

25.4

22.5

27.2

Min

100.0

100.0

100.0

Max
25th

505.2
7943

0.8
0.1

505.2
4061

0.8
0.1

<.0001

122.3

75th

Median

<.0001

9.6

Mean

25th

Height-for-age z-score

9.3

376.8
3882

0.8

.4454

0.1

75th

1.5

1.5

1.5

Mean

0.8

0.8

0.8

STD

1.1

1.1

1.1

Min

-3.7

-3.7

-3.6

Max

3.7

3.7

3.7

All tests treat the column variable as nominal.
Abbreviations: BP, blood pressure; NH, non-Hispanic; BMI, body mass index; %BMIp95, percentage of the 95th BMI percentile.
a
High BP includes elevated, stage 1 and stage 2.
b
Obesity Class: class 1, 100% to < 120% %BMIp95; class 2, 120% to < 140% %BMIp95; class 3, ≥140% %BMIp95.
c
P-values are based on Pearson chi-square tests for all categorical row variables.
d
P-values for comparing ordinal categorical variables and continuous variables are based on chi-square rank based group means score statistics. This is equivalent to
Kruskal-Wallis tests. All tests treat the column variable as nominal.
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TA B L E 2 Generalized linear multivariable model examining association of characteristics with being in the high BP group compared to normal
BP group based on 2017 AAP CPG BP interpretations7
Univariate analysis+

Multivariate analysis†

OR (95% CI)

p value

OR (95% CI)

p value

Male

1.44 (1.30, 1.59)

<.0001

1.41 (1.27, 1.56)

<.0001

Female

Ref

Characteristics
Sex

Ref

Age groups
3–5 years

0.69 (0.54, 0.89)

.0042

0.65 (0.50, 0.85)

.0012

6–8 years

0.57 (0.48, 0.68)

<.0001

0.57 (0.48, 0.68)

<.0001

9–11 years

0.60 (0.52, 0.69)

<.0001

0.63 (0.54, 0.73)

<.0001

12–14 years

0.64 (0.55, 0.74)

<.0001

0.64 (0.55, 0.75)

<.0001

15–17 years

Ref

Ref

Race/ethnicity
Black NH

0.89 (0.77, 1.02)

.0972

0.84 (0.72, 0.97)

.0212

Hispanic

0.86 (0.75, 0.98)

.0253

0.91 (0.79, 1.05)

.1908

Other and multiracial NH

0.92 (0.73, 1.15)

.4688

0.97 (0.77, 1.22)

.7735

White NH

Ref

Ref

Insurance type
Public

0.98 (0.88, 1.09)

.6829

0.95 (0.85, 1.07)

.4203

Self-pay/none

0.98 (0.58, 1.65)

.9463

1.04 (0.61, 1.78)

.8767

Private

Ref

Ref

Obesity classa
Class 3

2.46 (2.16, 2.80)

<.0001

2.39 (2.10, 2.73)

<.0001

Class 2

1.43 (1.26, 1.62)

<.0001

1.42 (1.25, 1.62)

<.0001

Class 1

Ref

Ref
7

Abbreviations: BP, blood pressure; AAP CPG, American Academy of Pediatrics Clinical Practice Guideline ; OR, odds ratio; Ref, reference; NH, non-Hispanic.
a
Obesity Class: class 1, 100% to < 120% %BMIp95; class 2, 120% to < 140% %BMIp95; class 3, ≥140% %BMIp95.
+
Includes site as a random effect.
†
Includes site as a random effect and other characteristics in the model.

contributing data with a median of 131 patients per site in anal-

severe obesity and males were more likely to have high BP (Table 2).

yses (interquartile range [IQR], 56–223 patients; range, 2–1239

Younger age groups (3–5, 6–8, 9–11, 12–14 years) were less likely to

patients).

have high BP compared to youth ages 15–17 years. White NH youth

Nearly half of patients (3882/7943, 48.9%) had BP interpreted as

were more likely to have high BP status as compared to Black NH youth,

high BP (18.9% elevated, 23.9% stage 1, and 6.0% stage 2) and 51.1%

but were similar to Hispanic and Other/Multiracial NH groups. Insur-

had normal BP. High BP was found for 60.0% of youth with class 3 obe-

ance group did not significantly predict BP group status.

sity, 45.9% with class 2 obesity, and 37.7% with class 1 obesity, (Table 1).

The next multivariate analyses again evaluated the 6752 patients

Highest frequency of high BP status occurred in older teens, males,

with complete data to examine factors associated with being in the

and for White NH youth and those of unknown race/ethnicity status

stage 1/stage 2 BP group (n = 2021, 29.9%) as compared to the nor-

(Table 1). Descriptive data for continuous variables (age, %BMIp95, and

mal/elevated BP group (n = 4731, 70.1%). Youth with severe obesity and

HtZ) are also presented in Table 1. Table S1 (online) presents these

males were more likely to be in the stage 1/stage 2 BP group (Table 3).

data for four BP interpretation groups: normal BP (51.1%); elevated

However, as compared to youth ages 15–17 years, only those in the 12-

BP (18.9%); stage 1 hypertension (23.9%); and stage 2 hypertension

14-year age group were less likely to be in the stage 1/stage 2 BP group;

(6.0%).

with no significant differences found between other age groups com-

As a next step, the first multivariate analysis evaluated the 6752
patients with complete data; 1191 patients (15.0%) were excluded due

pared to youth ages 15–17 years. Neither race/ethnicity nor insurance
group significantly predicted BP group status.

to missing race/ethnicity and/or missing insurance group. The first anal-

The percentage of patients with high BP varied between sites.

ysis evaluated factors associated with being in the high BP (n = 3311,

For sites with > 100 patients in the analyses (n = 21), the median

49.0%) versus the normal BP group (n = 3441, 51.0%). Youth with

percentage of patients with high BP at the initial visit was 50.4%

127

BINNS ET AL .

TA B L E 3 Generalized linear multivariable model examining association of characteristics with being in the Stage 1/Stage 2 BP group
compared to the normal/elevated BP group based on 2017 AAP CPG BP interpretations7
Univariate analysis+

Multivariate analysis†

OR (95% CI)

p value

OR (95% CI)

p value

Male

1.31 (1.18, 1.46)

<.0001

1.25 (1.12, 1.40)

<.0001

Female

Ref

Characteristics
Sex

Ref

Age groups
3–5 years

1.07 (0.81, 1.39)

.6443

1.01 (0.77, 1.33)

.9501

6–8 years

0.96 (0.80, 1.15)

.6503

0.98 (0.81, 1.17)

.7943

9–11 years

0.89 (0.76, 1.04)

.1486

0.97 (0.82, 1.13)

.6804

12–14 years

0.68 (0.58, 0.79)

<.0001

0.69 (0.58, 0.81)

<.0001

15–17 years

Ref

Ref

Race/ethnicity
Black NH

0.95 (0.82, 1.11)

.5515

0.87 (0.74, 1.02)

.0855

Hispanic

0.83 (0.73, 0.95)

.0049

0.91 (0.77, 1.06)

.2228

Other and multiracial NH

1.02 (0.79, 1.30)

.8976

1.05 (0.81, 1.35)

.7298

White NH

Ref

Ref

Insurance type
Public

1.05 (0.93, 1.18)

.4558

0.99 (0.88, 1.13)

.9205

Self-pay/none

0.91 (0.51, 1.62)

.7404

0.95 (0.52, 1.71)

.8531

Private

Ref

Ref

Obesity class*
Class 3

2.77 (2.39, 3.21)

<.0001

2.75 (2.37, 3.20)

<.0001

Class 2

1.54 (1.32, 1.79)

<.0001

1.54 (1.32, 1.79)

<.0001

Class 1

Ref

Ref
7

Abbreviations: BP, blood pressure; AAP CPG, American Academy of Pediatrics Clinical Practice Guideline ; OR, odds ratio; Ref, reference; NH, non-Hispanic.
*Obesity Class: class 1, 100% to < 120% %BMIp95; class 2, 120% to < 140% %BMIp95; class 3, ≥140% %BMIp95.
+
Includes site as a random effect.
†
Includes site as a random effect and other characteristics in the model.

(IQR 36.4–56.1%; range 25.5–80.7%). For sites with ≤100 patients in

and coworkers study, 45% of patients had severe obesity (defined for

the analyses (n = 14), the median percentage of patients with high BP at

the study as BMI > 99.5th percentile)17 and in national surveys approx-

the initial visit was 63.5% (IQR 54.9–76.6%; range 30.6–100%).

imately one-third of patients had severe obesity.5,8,18 In this report and
prior POWER reports severe obesity status was reported for threequarters of the patients11,18 ; among youth with most severe (class

4

3) obesity ∼60% had high BP. Youth with hypertension and obesity

DISCUSSION

are often referred for PWM services due to the need for a multiHypertension is a serious comorbidity associated with obesity across
all ages, including

children.15,16

This study found that nearly half of

treatment-seeking youth with obesity had high BP. This rate is higher

disciplinary team approach available in these centers,19,20 and that
may also have been a contributing factor to the high rates of high BP
observed in this sample.

than previous studies. For example, Reinehr and coworkers, reported

Many of the characteristics significantly associated with high BP

that among a sample of treatment-seeking youth aged 4–18 years with

in the initial visit for treatment-seeking youth with obesity were as

overweight and obesity and having BP assessed using a standardized

expected. Youth with severe obesity status were at increased risk

protocol, 37% had BP > 95th percentile compared to a large US refer-

for high BP. Reinehr and coworkers found that obesity severity is an

ence sample.17 A previous report found that for youth 12–17 years in

important risk for high BP.17 Jackson and coworkers, using 2013–2016

POWER, systolic and diastolic BP values were significantly higher as

NHANES data, reported high BP for 27.5% of youth with obesity, with

compared to a sample of youth with obesity selected from national sur-

highest frequency among youth with severe obesity (30.6%).8 Older

vey

evaluations.18

Differing rates of severe obesity between studies

youth were significantly more likely to have high BP. Similar results

may be the reason for variation in the rates of high BP. In the Reinehr

were reported by Reinehr and coworkers.17 Several large community
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samples21,22 and a recent report of national data9 have also reported

sure monitoring, echocardiogram evaluations, or require prompt initi-

increased risk for high BP as children age.

ation of antihypertensive medications.7 PWM clinicians should incor-

Males more frequently had high BP as compared to females, as was

porate initial recommended hypertension management strategies such

also found in national surveys.9,23 The AAP CPG accounts for expected

as nutritional and activity counseling as core components of an

sex-related BP differences for interpretations for youth ages 3–12

intensive lifestyle intervention.7 An effective nutritional strategy to

years, but both male and female youth ages 13–17 are evaluated using

reduce incidence of hypertension in youth has been application of a

the same cut points.7 This may have also been a contributing factor to

Dietary Approaches to Stop Hypertension (DASH)-style diet.27 This

our findings, since about 45% of youth in this evaluation were ages 12–

diet includes: increased intake of fruits, vegetables, nuts, legumes and

17 years.

whole grains; low-fat dairy products; lean meats, poultry, and fish

This study did not examine characteristics associated with the high

(while limiting red and processed meats); and limiting sweets, sugar-

BP group for males and females separately but found that when males

containing beverages and sodium.27 Medical interventions in PWM

and females were considered as a group, Black NH youth had lower

can lead to improvements in BP,28,29 even over periods as short as 6

risk for high BP as compared to White NH youth. Other studies have

months.29 In adults, a weight loss of 1 kg was found to be associated

reported disparate findings on racial/ethnic differences in likelihood of

with -1.05 mm Hg and -0.92 mm Hg changes in systolic and diastolic BP,

high BP. A study of BP elevation in youth with obesity found higher risk

respectively.30 Among adolescents with overt hypertension there are

for Hispanic males as compared to White males, with similar risk for

also several factors (eg, insulin resistance, levels of pro-inflammatory

Black and White males and no racial/ethnic differences in risk for BP

cytokines) that indicate higher risk of concurrent subclinical disease,

elevation among females.24 A large community sample also reported

persistent adult hypertension, and adult cardiovascular disease.31 Clin-

slightly lower risk for elevated BP among African American youth as

ical PWM programs may benefit substantially from more aggressive

compared to White youth.25 In contrast, an evaluation of a national

antihypertensive pharmacological treatments and referral to other

sample of youth ages 8–12 years found higher prevalence of high BP

subspecialists (eg, nephrologist or cardiologist) for further evaluation

among Asian NH youth, as compared to White NH youth with no sig-

and pharmacotherapy.

years.9

It

These data were obtained during clinical care and show substan-

has been suggested that racial/ethnic differences are developed during

tial between-site variability in frequency of youth with high BP. The

adolescence,7,26 so expected difference would depend on ages of the

between-site variability may reflect, to some degree, differences in

youth being studied.

patient populations across sites, but also highlights the importance of

nificant difference by race/ethnicity for youth ages 13–17

There was no difference in the frequency of high BP between

ensuring use of recommended protocols for BP measurement,7 includ-

those with public and private insurance. In contrast, a community sam-

ing adequate BP cuff size and repeated manual measurements, if nec-

ple reported slightly higher odds for elevated BP among those with

essary. A study of outpatient visits at one pediatric tertiary care insti-

public insurance or uninsured, as compared to commercially insured

tution reported 36% of BP readings to be high, but across institutional

patients.25

subspecialties this varied from 12.4% to 65.2%, with the PWM program

The second logistic regression examined factors associated with
having stage 1 or stage 2 hypertension as compared to patients in

having high BP frequency at rates similar to the Kidney Disease division
(∼48%).32

the normal/elevated BP group. Compared to the first logistic regression,

BP data for this study were collected during clinical care and

findings were similar for risks of severe obesity and being male, but

entered the POWER database as a single BP measurement; there-

findings for age group and race/ethnicity differed. Only youth ages 12–

fore, the frequency of sites performing single versus duplicate BP mea-

14 years were less likely to have stage 1 or stage 2 hypertension com-

surements is unknown. A single BP measurement value does not fulfill

pared to youth ages 15–17 years; all other age groups were similar to

guideline requirements for repeated measurements at visits.7 When

youth ages 15–17 years. This indicates that in the first logistic regres-

an initial BP value is interpreted as elevated, two additional auscul-

sion youth ages 2–11 years with BP assessed as elevated were driv-

tatory measurements should be taken and averaged to define the BP

ing the difference found for the comparison with the 15–17-year age

category.7 Repeated BP measurements may not be a routine part of

age,26

youth ages 13–14 years evalu-

primary care visits,33 and repeated measurements may be particu-

ated by the same standard at youth 15–17 years would be expected to

larly important for youth with overweight or obesity.34,35 Repeated

have lower likelihood of being in the stage 1/stage 2 BP group, and this

measurements better predict longer-term BP status.36 Additionally, to

may have contributed to the findings reported. Youth ages 3–12 years

assign a diagnosis of hypertension requires identification of elevated

have BP interpretations evaluated in relationship to age and height and

BP measurements at three different occasions.7,15

group. Since BP increases with

that strategy provides gradual change in BP interpretation cut point

There is a substantial selection bias for youth in this evaluation that

that accounts for the gradual rise in BP as youth age. Also, in this second

can explain differences with data from random samples from a gen-

logistic regression, having fewer patients, neither race/ethnicity nor

eral population. Treatment-seeking youth more frequently have severe

insurance were significant factors predicting being in the stage 1/stage

obesity, a risk for hypertension, compared to general population sam-

2 BP group.

ples. Additionally, treatment-seeking youth with obesity may be at sub-

High BP may prompt the need for further evaluation, such as

stantially higher risk for hypertension, as BP measurements at a pri-

repeated BP assessments at future visits, ambulatory blood pres-

mary care visit may have been the factor initiating a PWM program
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referral. Further study will be needed to identify which youth will fulfill

drafted the manuscript. Helen Binns, Madeline Joseph, Sarah Hampl,

hypertension criteria across repeated measurement encounters. For

and Shelley Kirk conducted literature searches. All authors provided

some youth, additional evaluations may be needed to better under-

critical revisions and approved the final version.

stand BP in clinical and home settings. Ambulatory BP monitoring may
be needed to identify white-coat hypertension, possibly induced by the
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4.1

Strengths and limitations

to Duke University through a grant from the American Heart Association Strategically Focused Research Network (17SFRN33670990,
17SFRN33671003; principal investigator, Asheley C. Skinner, PhD).

These data present information on nearly 8000 youth presenting
for PWM care with the majority having severe obesity. Such information can foster the development of multidisciplinary strategies to
address obesity and hypertension and help PWM programs to realize the high frequency at which they will need to optimally measure BP and treat elevated BP with appropriate lifestyle changes and
pharmacotherapy.31
While a limitation within POWER is the lack of information about
BP measurement validation, these data were obtained during clinical
care and highlight the diversity of the frequency of high BP between
PWM programs. Individual PWM programs may wish to examine the
frequency of high BP for their program in comparison to these data and,
as necessary, review adherence to protocols for BP measurement.
Some patients may have already had a diagnosis of hypertension
and were receiving antihypertensive medications for treatment at the
time of their initial PWM visit. Diagnoses and medications were not
uniformly collected and thus were not analyzed. Clearly, given this
high frequency of high BP in this study, many PWM patients may
need additional support to address hypertension and PWM clinicians
will need to monitor if youth are taking antihypertensive medications
as prescribed. Despite limitations, these data identify the high frequency of and important considerations for risk of high BP among
treatment-seeking youth with obesity which can prompt PWM programs to develop strategies to address high BP in the youth they serve.

5

CONCLUSIONS

Nearly half of youth seeking PWM obesity care had BP values classified as high. Males, older teens, and youth with severe obesity were at
highest risk for high BP. There were substantial differences in prevalence of high BP between POWER sites. Standardized, protocol-driven
assessments and management of high BP should be key areas of focus
for PWM programs.
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